ライフサイエンスコーパス: lipid emulsion

1 tandard dose) of total daily energy as a 20% lipid emulsion.

2 ability of phylloquinone from an intravenous lipid emulsion.

3 n containing 10% fish oil or a fish oil-free lipid emulsion.

4 l pressure was observed in rats treated with lipid emulsion.

5 c arrest before and after resuscitation with lipid emulsion.

6 cue of bupivacaine-induced cardiotoxicity by lipid emulsion.

7 shown for this treatment nor for the type of lipid emulsion.

8 esent naturally, in variable amounts, in the lipid emulsion.

9 and avoidance of complications from amended lipid emulsions.

10 r amino acid intakes and fish oil-containing lipid emulsions.

11 rly in low-birth-weight neonates who receive lipid emulsions.

12 a cells without the aid of viral vectors and lipid emulsions.

13 owel mucosa by VV-TPN as opposed to standard lipid emulsions.

14 lic actions compared with available standard lipid emulsions.

15 iled characterization of the in vivo fate of lipid emulsions.

16 ess to bitter-tasting stimuli, as well as to lipid emulsions.

17 (Intralipid) or olive oil-based (ClinOleic) lipid emulsions.

18 of the following 4 different fat emulsions: lipid emulsion 1 (LE1; acid stable, 0.33 mum), lipid emu

19 one patients (81%) received a fish oil-based lipid emulsion (1 g/kg/d), 40 (63%) were weaned, 11 (17%

20 ment with one of the following: intraosseous lipid-emulsion (10 mL/kg over 180 s), intraosseous salin

21 ntraosseous saline (10 mL/kg over 180 s), IV lipid-emulsion (10 mL/kg over 90 s), or no treatment (sh

22 at a similar rate to animals treated with IV lipid emulsion (176 s [152-217 s], p = not significant).

23 pid emulsion 1 (LE1; acid stable, 0.33 mum), lipid emulsion 2 (LE2; acid stable, 52 mum), lipid emuls

24 lipid emulsion 2 (LE2; acid stable, 52 mum), lipid emulsion 3 (LE3; acid unstable, solid fat, 0.32 mu

25 E3; acid unstable, solid fat, 0.32 mum), and lipid emulsion 4 (LE4; acid unstable, liquid fat, 0.38 m

26 d radiolabeled triglyceride derived from the lipid emulsion (a surrogate for chylomicrons; extraction

27 randomized to receive one of three doses of lipid emulsion administered twice in 48 hours or no drug

28 d the fatty acids present in the intravenous lipid emulsion administered: omega-6 linoleic acid (rang

29 We sought to test if IV lipid emulsion administration to sepsis patients with lo

30 n compared to the group that did not receive Lipid Emulsion after bupivacaine overdose (330+/-42 nmol

31 using infusions of a [(3)H]triolein-labeled lipid emulsion and [U-(13)C]oleate during continuous fee

32 nvestigate the metabolism of a n-3 PUFA-rich lipid emulsion and a n-6 PUFA-rich lipid emulsion in a m

33 stricting the dose of parenteral soybean oil lipid emulsion and/or replacing the soybean oil with a p

34 eous lipid emulsion, intraosseous saline, IV lipid emulsion, and sham/null.

35 Lipid emulsions are a key component of total parenteral

36 New details on the effects of amended lipid emulsions are presented, together with a meta-anal

37 3)H triolein, the latter incorporated into a lipid emulsion as a surrogate for chylomicrons.

38 inical reports have led to the acceptance of lipid emulsion as an effective treatment of local anesth

39 Glucagon-like peptide-2, and lipid emulsions based less on soy-bean oil appear safe a

40 rapy, rescues behavioral responsiveness to a lipid emulsion but not to bitter stimuli and that this r

41 Bolus infusion of lipid emulsion can reverse cardiac pharmacotoxicity caus

42 Lipid emulsions, choline deficiency, and manganese toxic

43 Rats were infused with glucose and the lipid emulsion ClinOleic and received SKI II by gavage.

44 ria isolated from rats resuscitated with 20% lipid emulsion compared to the group that did not receiv

45 amics of binding of apoA-I to lipid, we used lipid emulsions composed of triolein (TO) and egg phosph

46 this effect, rats were infused with either a lipid emulsion (consisting mostly of 18:2 fatty acids) o

47 parenteral nutrition prepared either with a lipid emulsion containing 10% fish oil or a fish oil-fre

48 sition and 2) the effect of a multicomponent lipid emulsion containing 30% soybean oil, 30% medium-ch

49 A lipid emulsion containing 4 mm phospholipid, 13.33 mm [(

50 -h fast during infusion of [14C]oleate and a lipid emulsion containing [3H]triolein; the emulsion was

51 Combination lipid emulsions containing fish oil are associated with

52 The effects of lipid emulsions containing medium-chain triglycerides, c

53 Composite lipid emulsions containing soybean oil (30%), medium-cha

54 Subjects received infusions of lipid emulsions containing triolein labeled with (3)H on

55 cosa, and triggering drug precipitation upon lipid emulsion depletion (e.g., by digestion).

56 ty-enhancing properties of a newly developed lipid emulsion designed for TPN use based on 18-carbon n

57 in which mice are trained to self-administer lipid emulsions directly into the stomach, we show that

58 ting for the proactive evidence-based use of lipid emulsions enriched with omega-3 PUFAs.

59 Lipid emulsion exerts rapid, positive inotropic and posi

60 Rats treated with intraosseous lipid emulsion experienced a significantly faster recove

61 recent literature involving a fish oil-based lipid emulsion (FOLE) and its effects on PNALD.

62 A fish-oil-based lipid emulsion (FOLE) as a component of PN can reverse P

63 We aimed to develop a novel lipid emulsion for TPN use with superior immunometabolic

64 1) assess the effect on iron absorption of a lipid emulsion given 20 min before or together with an i

65 n erythrocytes 14 d after the test meals.The lipid emulsion given either before or with the meal sign

66 Lipid emulsion has been shown to be effective in resusci

67 Furthermore, lipid emulsion has been used with apparent success early

68 Lipid emulsion has emerged as an effective treatment of

69 The role of lipid emulsion has expanded to treatment of cardiac toxi

70 orial in etiology, components of soybean oil lipid emulsions have been implicated in the disease's pa

71 Lipid emulsions have evolved from simple energy sources

72 mpared with TPN containing soybean oil-based lipid emulsion (IL-TPN) and fish-oil-based lipid emulsio

73 orida, our objective was to test intravenous lipid emulsion (ILE) as a rapid treatment for brevetoxic

74 and efficacy of a fish oil-based intravenous lipid emulsion (ILE) in the treatment of parenteral nutr

75 Fish oil (FO) intravenous lipid emulsions (ILEs) are used as a monotherapy to trea

76 ately 0.3 mM) was prevented by infusion of a lipid emulsion in 15 conscious rats (plasma FFA approxim

77 PUFA-rich lipid emulsion and a n-6 PUFA-rich lipid emulsion in a mouse model of TPN and in primary hu

78 d with (LIP+) and without (LIP-) infusion of lipid emulsion in nine nondiabetic individuals.

79 otal of 51 patients received olive oil-based lipid emulsion in parenteral nutrition (age 46 +/- 19 yr

80 A FOLE may be the preferred lipid emulsion in patients with PN-cholestasis, dyslipid

81 cue of bupivacaine-induced cardiotoxicity by lipid emulsion in rats.

82 The infusion of lipid emulsion in the isolated heart dose-dependently in

83 Lipid emulsion in this rat model provides superior hemod

84 While lipid emulsions in modern formulations for total parente

85 nts a consensus on the biological aspects of lipid emulsions in parenteral nutrition, emphasizing the

86 The use of intravenous lipid emulsions in preterm infants has been limited by c

87 mes associated with the use of n-3 PUFA-rich lipid emulsions in TPN.

88 Components of PN lipid emulsions, including plant sterols, interact with

89 Lipid emulsions increased the DNA-binding activity of NF

90 0 mg/kg over 20 secs, intravenously) and 20% lipid emulsion infusion (5 mL/kg bolus, and 0.5 mL/kg/mi

91 Lipid emulsion infusion appears to be an effective treat

92 The authors test the hypothesis that lipid emulsion infusion exerts direct, positive inotropi

93 Lipid Emulsion infusion improved the cardiac function gr

94 Lipid emulsion infusion is an emerging antidotal therapy

95 tion from bupivacaine-induced asystole using lipid emulsion infusion vs. vasopressin, alone and with

96 ne group before and after resuscitation with lipid emulsion infusion.

97 (-1). min(-1)), and Liposyn (heparinized 10% lipid emulsion) infusions were initiated simultaneously

98 re warranted to optimize this novel route of lipid emulsion injection in emergency situations when in

99 using chylomicrons as well as the synthetic lipid emulsion Intralipid.

100 gh-carbohydrate liquid diet plus intravenous lipid emulsion (Intralipid, 4 g fat/kg/d) or intravenous

101 e-Dawley rats into four groups: intraosseous lipid emulsion, intraosseous saline, IV lipid emulsion,

102 oxicity occurs primarily at sodium channels, lipid emulsion is a reasonably well tolerated and effect

103 compressions, and randomized to receive 30% lipid emulsion (L, 5 mL/kg bolus then 1.0 mL/kg/min infu

104 (14)C oleate and a lipid emulsion labeled with (3)H triolein were infused t

105 istration of parenteral nutrition, including lipid emulsion (LE), to patients via medical catheters i

106 Literature suggests mixed lipid emulsions (LE) with soybean oil reduction strategi

107 eral nutrition (PN) with vegetable oil-based lipid emulsions (LEs).

108 min, hyperbaric oxygen, insulin, intravenous lipid emulsion, lidocaine, methylene blue, naloxone, pra

109 ultures of rat hepatocytes were treated with lipid emulsions, linoleic or oleic acid, and UCP-2 expre

110 Recently, we have shown that intravenous lipid emulsion (liposyn) infusion during a 120-min eugly

111 riod 2, saline (nicotinic acid [NA], n = 7), lipid emulsion (NA plus lipid emulsion [NAL], n = 8), or

112 c acid [NA], n = 7), lipid emulsion (NA plus lipid emulsion [NAL], n = 8), or glycerol (NA plus glyce

113 l (SMOF) with that of soybean oil (SO)-based lipid emulsion on intrahepatocellular lipid (IHCL) conte

114 The acute effects of lipid emulsions on gastric emptying, gallbladder volume,

115 g the soybean oil with a parenteral fish-oil lipid emulsion or emulsions of mixed-lipid sources.

116 photericin B delivered as a locally prepared lipid emulsion or in liposomes reduced nephrotoxicity to

117 data to warrant wholesale switching to novel lipid emulsions or the global use of glutamine or growth

118 Here, we infused 20% Intralipid (a synthetic lipid emulsion) or saline intraduodenally for 90 min at

119 d lipid emulsion (IL-TPN) and fish-oil-based lipid emulsion (OV-TPN).

120 -III molecule are critical for attachment to lipid emulsion particles and consequently inhibition of

121 Perfluorocarbons (PFCs) are lipid emulsion particles with great flexibility and thei

122 articles (phospholipid unilamellar vesicles, lipid emulsion particles) gave rise to stoichiometric li

123 III inhibit lipolysis by displacing LPL from lipid emulsion particles.

124 the unanimous support for the integration of lipid emulsions, particularly those containing fish oil,

125 for control patients and -2 (IQR -3, 0) for lipid emulsion patients ( p = 0.46).

126 Mean change in triglycerides was elevated in lipid emulsion patients (61 mg/dL, sd 87) compared with

127 Data for 24 control patients and 23 lipid emulsion patients were analyzed.

128 between groups and was 5 mg/dL ( sd 20) for lipid emulsion patients, and 2 mg/dL ( sd 18) for contro

129 data indicate that intraosseous infusion of lipid emulsion rapidly reverses bupivacaine-induced card

130 aining soybean oil-based and olive oil-based lipid emulsion resulted in similar rates of infectious a

131 Lipid emulsions rich with n-6 (omega-6) PUFAs are known

132 ajor compositional components of intravenous lipid emulsions routinely administered to preterm infant

133 ding fat administered as a soybean oil-based lipid emulsion (SOLE), is a life-saving therapy but may

134 By assessing different lipid emulsions (soy lecithin, milkfat globule membrane

135 t is more effectively treated by intravenous lipid emulsion than by epinephrine.

136 The next day, the infusate was changed to a lipid emulsion that contained (14C) cholesterol and (3H)

137 rmine whether early initiation of lipids and lipid emulsions that are not purely soybean oil-based re

138 proinflammatory effects of soybean oil-based lipid emulsions, the only Food and Drug Administration-a

139 of a patient successfully resuscitated with lipid emulsion therapy after prolonged and intractable l

140 te a case report involving successful use of lipid emulsion therapy for intractable cardiac arrest du

141 Intravenous lipid emulsion therapy has the potential to reduce rehab

142 This case demonstrates the need to consider lipid emulsion therapy in the advanced cardiac life supp

143 The mechanism of action of lipid emulsion therapy is not well defined and has been

144 lation, oxygenation, and chest compressions, lipid emulsion therapy should be a primary element in th

145 ental doses of high-dose insulin (1D) and IV lipid-emulsion therapy (1D) if not already tried.

146 standard advanced cardiac life-support (1D), lipid-emulsion therapy (1D), and we suggest venoarterial

147 f myocardial dysfunction is present (2D), IV lipid-emulsion therapy (2D), and using a pacemaker in th

148 Administration of IV lipid emulsion to early sepsis patients with low cholest

149 Study 2 used an intravenous lipid emulsion to increase FFA concentrations during inf

150 ement of intragastric self-administration of lipid emulsions to determine the extent to which postora

151 gies, including modifications of intravenous lipid emulsions to reduce pro-inflammatory fatty acids a

152 Intralipid is a lipid emulsion used for preterm infants, but its biologi

153 Vegetable oil-based lipid emulsions (VBLEs) contribute to PNALD.

154 A novel lipid emulsion [Vegaven (VV)] containing 30% of 18-carbo

155 In studies 1 and 2, a lipid emulsion was given with or 20 min before the meal.

156 Lipid emulsion was only able to rescue rats pretreated w

157 A drop of the lipid emulsion was then instilled; 15 minutes later, two

158 Two patients randomized to lipid emulsion were withdrawn before drug administration

159 We questioned whether the catabolism of lipid emulsions would be changed after enrichment with f